Seizure after withdrawal from supratherapeutic doses of Zolpidem tartrate, a selective omega I benzodiazepine receptor agonist

Journal of Pain and Symptom Management

Volumn 14, Issue 2, 1997, Pages 118-120

  Gilbert, Donald L ^a   Staats, Peter S ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; DESIPRAMINE; OXYCODONE; ZOLPIDEM TARTRATE;

ADULT; ARTICLE; CASE REPORT; CHRONIC PAIN; DOSE RESPONSE; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; INSOMNIA; MALE; MOTORCYCLE; PERINEUM INJURY; SEIZURE; TRAFFIC ACCIDENT;

ADULT; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PYRIDINES; RECEPTORS, GABA-A; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030820047     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(97)00017-1     Document Type: Article

References (11)

1. Bonica JJ. General considerations of chronic pain. In: Bonica JJ, ed. The Management of Pain. Lea & Febiger: Philadelphia, 1990:180.
2. Abramowicz M. Zolpidem for insomnia. Med Lett Drugs Ther 1993;35:35-36.
3. Ashton H. Adverse effects of prolonged benzo-diazepine use. Adverse Drug React Bull 1986;118: 440-443.
4. Cavallaro RM, Covelli G, Smeraldi E. Tolerance and withdrawal with zolpidem. Lancet 1993;342: 374-375.
5. Depoortere H, Zivkovic B, Lloyd IG, Sanger DJ, Perrault G, et al. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects. J Pharmacol Exp Ther 1986;237: 649-658.
6. Evans SM, Funderburk FR, Griffiths RR. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 1990;255:1246-1255.
7. Gericke C. Chronic abuse of zolpidem. JAMA 1994;272:1720-1721.
8. Griffiths RR, Sannerud CA, Ator NA, Brady JV. Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 1992;260:1199-1207.
9. Langer SZ, Arbilla S, Scatton B, Niddam R, Dubois A. Receptors involved in the mechanism of action of zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in Sleep Disorders. New York: Raven, 1988:55-70.
10. Perrault G, Morel E, Sanger DJ, Zivkovic B. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Psychopharmacol 1992:298-303.
11. Piercey MF, Hoffmann WE, Cooper M. The hypnotics triazolam and zolpidem have identical metabolic effects throughout the brain: implications for benzodiazepine receptor subtypes. Brain Res 1991:244-252.